Page last updated: 2024-08-02 13:16:07

tacamonine

Description

tacamonine: structure in first source [MeSH]

Cross-References

ID SourceID
PubMed CID9971698
SCHEMBL ID1944441
MeSH IDM0417954

Synonyms (3)

Synonym
SCHEMBL1944441
tacamonine
(13r,15r,19r)-13-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-one

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
indoleindole;
polycyclic heteroarene
Escherichia coli metabolite2006200618.0low000100
vincaminealkaloid ester;
hemiaminal;
methyl ester;
organic heteropentacyclic compound;
vinca alkaloid
antihypertensive agent;
metabolite;
vasodilator agent
2001200123.0low000100
paroxetinearomatic ether;
benzodioxoles;
organofluorine compound;
piperidines
antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
2005200519.0low000100
dauricinearomatic ether;
bisbenzylisoquinoline alkaloid;
isoquinolines;
phenols;
tertiary amino compound
plant metabolite202020204.0medium000010
dihydrocorynantheol2006200618.0medium000100
sesquiterpenes202020204.0low000010
rhyncophylline2006200618.0low000100
deplancheine2005200519.0high000100
vindeburnol2001200123.0medium000100
piperidines2005200618.5medium000200
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020